HOME

RINVOQ

HUMIRA

SKYRIZI

EDUCATION

SERVICES

CONTACT

AbbVie Pharmacy supports advancing the standard
of care in pharmacy practice

We partner to tackle global health challenges and
shape the future of disease management in support of
a brighter future for patients.

AbbVie Pharmacy supports advancing the standard of care in pharmacy practice

We partner to tackle global health challenges and
shape the future of disease management in support of
a brighter future for patients

Featured education and services for you


About RINVOQ

Upadacitinib is an oral medication used to treat a number of immune-mediated inflammatory diseases.

Destination Pharmacy

A pharmacy network supporting patients between medical appointments.

Patient support

Services and tools for your HUMIRA and SKYRIZI patients on their treatment journey.

Stock replacement

Return expired or incorrectly ordered HUMIRA stock.

News and events


Pharmacist CPD education

Learn about the HUMIRA citrate-free formulation, 80 mg presentation and re-designed Pen.

HUMIRA dispensing guide

Quick access to the concise HUMIRA PBS listing for your reference in the dispensary.
 

This resource is currently unavailable.
Please contact your AbbVie Representative for further details.


PBS Information

RINVOQ: Authority required. Refer to PBS Schedule for full authority information.

HUMIRA: Authority required. Refer to PBS Schedule for full authority information. This product is not listed on the PBS for the treatment of enthesitis-related arthritis or paediatric psoriasis.

SKYRIZI: Authority required for the treatment of adults with severe plaque psoriasis. SKYRIZI is not listed on the PBS for the treatment of psoriatic arthritis. Refer to PBS Schedule for full authority information.

Please review the full Product Information (PI) before prescribing, available below.

AU-HUM-220152. June 2024